Jpmorgan Chase & CO Prime Medicine, Inc. Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 37,382 shares of PRME stock, worth $119,622. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37,382
Previous 38,187
2.11%
Holding current value
$119,622
Previous $196,000
26.53%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding PRME
# of Institutions
123Shares Held
64.7MCall Options Held
324KPut Options Held
64.4K-
Alphabet Inc. Mountain View, CA15.1MShares$48.2 Million3.99% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl5.66MShares$18.1 Million0.21% of portfolio
-
Black Rock Inc. New York, NY5.11MShares$16.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.89MShares$15.6 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.81MShares$12.2 Million0.01% of portfolio
About Prime Medicine, Inc.
- Ticker PRME
- Shares Outstandng 95,730,200
- Market Cap $306M